Page 3 - Virtual Biotech News Today

Parkinsons UK Implements CDD Vault to Manage Its Pioneering Drug Discovery Data USA - English Share this article Share this article LONDON and SAN FRANCISCO, July 19, 2021 /PRNewswire/ -- Parkinsons UK, the largest charitable funder of Parkinsons research in Europe, has announced today that it is using Collaborative Drug Discoverys CDD Vault informatics system to manage project data from the Parkinsons Virtual Biotech, its pioneering drug discovery arm. The Parkinsons Virtual Biotech, which l...

Parkinson’s UK, University of Sheffield to develop new Parkinson’s drug Parkinsons UK, the largest charitable funder of Parkinsons research in Europe, is investing up to £1.2 million into a pioneering one-year project in partnership with the University of Sheffield. The project aims to refine a molecule that could be developed into a drug to protect dopamine-producing brain cells and slow down the progression of Parkinsons. The funding boost comes via the charitys Parkinsons Virtual Biotec...

Researchers from the University of Sheffield's Institute of Translational Neuroscience (SITraN) have been awarded over £1 million from Parkinson's UK to...

UK charity provides £1.2 million ($1.7 million) in funding to refine molecule to protect dopamine-producing brain cells and slow down disease progression.

Parkinson’s UK creates Vivifi Biotech to research ‘promising’ experimental treatment 24th February 2021 Charity organisation Parkinson’s UK has announced it is creating a dedicated company to drive forward research into an experimental treatment for Parkinson’s disease. The company, Vivifi Biotech, has been created through the Parkinson’s Virtual Biotech – the drug development arm of Parkinson’s UK. It will seek to further the development of Glial Cell-Line Derived Neurotrophic ...